SCHEMBL30976334

SCHEMBL30976334

Cn1nc(C(=O)N2CCN(C(=O)OC(C)(C)C)CC2)c2cccnc2c1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.54
DTYMK P23919 2/20 0.52
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
ATM Q13315 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
ALDH1A1 P00352 4/20 0.46
NPSR1 Q6W5P4 2/20 0.46
MAPT P10636 1/20 0.46
GAA P10253 1/20 0.45
LMNA P02545 2/20 0.45
NPC1 O15118 1/20 0.45
NR2F2 P24468 1/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
GPR119 Q8TDV5 2/20 0.42
DRD2 P14416 1/20 0.41
HTR2A P28223 1/20 0.41
AKT1 P31749 1/20 0.41
EPHX2 P34913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30976347 0.85 MEN1 (0.69) POLBDTYMKMEN1KMT2AATM
SCHEMBL30976343 0.81 MEN1 (0.55) MEN1KMT2AATML3MBTL1ALDH1A1
SCHEMBL30976476 0.80 MEN1 (0.51) POLBDTYMKMEN1KMT2AATM
SCHEMBL30976251 0.80 MEN1 (0.51) POLBDTYMKMEN1KMT2AATM
SCHEMBL30976380 0.77 ALDH1A1 (0.54) POLBMEN1KMT2AALDH1A1NPSR1
SCHEMBL30976335 0.77 MEN1 (0.51) POLBMEN1KMT2AATML3MBTL1
SCHEMBL30976409 0.77 MEN1 (0.50) POLBDTYMKMEN1KMT2AATM
SCHEMBL30976241 0.77 MEN1 (0.50) POLBMEN1KMT2AATML3MBTL1
SCHEMBL19377001 0.75 KAT2B (0.67) DTYMKLMNANPC1NR2F2HTT
SCHEMBL30976294 0.74 KAT2B (0.46) POLBMEN1KMT2AL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4619387-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE Soley Therapeutics, Inc. (US) 2025-09-24 EP disclosed
WO-2024108131-A1 PHTHALAZINONE BASED MODULATORS FOR THE TREATMENT OF DISEASE SOLEY THERAPEUTICS, INC. (US) 2024-05-23 WO disclosed